201 related articles for article (PubMed ID: 27470218)
1. Four decades of stem cell transplantation for Fanconi anaemia in the Netherlands.
Smetsers SE; Smiers FJ; Bresters D; Sonnevelt MC; Bierings MB
Br J Haematol; 2016 Sep; 174(6):952-61. PubMed ID: 27470218
[TBL] [Abstract][Full Text] [Related]
2. The Saudi experience in fludarabine-based conditioning regimens in patients with Fanconi anemia undergoing stem cell transplantation: excellent outcome in recipients of matched related stem cells but not in recipients of unrelated cord blood stem cells.
Ayas M; Al-Seraihi A; El-Solh H; Al-Ahmari A; Khairy A; Aldali A; Markiz S; Siddiqui K; Al-Jefri A
Biol Blood Marrow Transplant; 2012 Apr; 18(4):627-32. PubMed ID: 21871862
[TBL] [Abstract][Full Text] [Related]
3. Transplant results in adults with Fanconi anaemia.
Bierings M; Bonfim C; Peffault De Latour R; Aljurf M; Mehta PA; Knol C; Boulad F; Tbakhi A; Esquirol A; McQuaker G; Sucak GA; Othman TB; Halkes CJM; Carpenter B; Niederwieser D; Zecca M; Kröger N; Michallet M; Risitano AM; Ehninger G; Porcher R; Dufour C;
Br J Haematol; 2018 Jan; 180(1):100-109. PubMed ID: 29094350
[TBL] [Abstract][Full Text] [Related]
4. Fludarabine-based cytoreductive regimen and T-cell-depleted grafts from alternative donors for the treatment of high-risk patients with Fanconi anaemia.
Chaudhury S; Auerbach AD; Kernan NA; Small TN; Prockop SE; Scaradavou A; Heller G; Wolden S; O'Reilly RJ; Boulad F
Br J Haematol; 2008 Mar; 140(6):644-55. PubMed ID: 18302713
[TBL] [Abstract][Full Text] [Related]
5. Allogeneic haematopoietic cell transplantation from alternative donors with a conditioning regimen of low-dose irradiation, fludarabine and cyclophosphamide in Fanconi anaemia.
Yabe H; Inoue H; Matsumoto M; Hamanoue S; Koike T; Ishiguro H; Koike H; Suzuki K; Kato S; Kojima S; Tsuchida M; Mori T; Adachi S; Tsuji K; Koike K; Morimoto A; Sako M; Yabe M
Br J Haematol; 2006 Jul; 134(2):208-12. PubMed ID: 16846479
[TBL] [Abstract][Full Text] [Related]
6. Bone marrow transplantation for Fanconi anemia using fludarabine-based conditioning.
Stepensky P; Shapira MY; Balashov D; Trakhtman P; Skorobogatova E; Rheingold L; Brooks R; Revel-Vilk S; Weintraub M; Stein J; Maschan A; Or R; Resnick IB
Biol Blood Marrow Transplant; 2011 Sep; 17(9):1282-8. PubMed ID: 21220033
[TBL] [Abstract][Full Text] [Related]
7. Non-TBI stem cell transplantation protocol for Fanconi anaemia using HLA-compatible sibling and unrelated donors.
de la Fuente J; Reiss S; McCloy M; Vulliamy T; Roberts IA; Rahemtulla A; Dokal I
Bone Marrow Transplant; 2003 Oct; 32(7):653-6. PubMed ID: 13130311
[TBL] [Abstract][Full Text] [Related]
8. Matched sibling donor haematopoietic stem cell transplantation in Fanconi anaemia: an update of the Cincinnati Children's experience.
Farzin A; Davies SM; Smith FO; Filipovich A; Hansen M; Auerbach AD; Harris RE
Br J Haematol; 2007 Feb; 136(4):633-40. PubMed ID: 17367413
[TBL] [Abstract][Full Text] [Related]
9. Successful Outcome With Fludarabine-Based Conditioning Regimen for Hematopoietic Stem Cell Transplantation From Related Donor in Fanconi Anemia: A Single Center Experience From Turkey.
Kuşkonmaz B; Ünal Ş; Bayhan T; Aytaç Eyüboğlu S; Tavil B; Çetin M; Gümrük F; Uçkan Çetinkaya D
Pediatr Blood Cancer; 2016 Apr; 63(4):695-700. PubMed ID: 26703084
[TBL] [Abstract][Full Text] [Related]
10. Excellent overall and chronic graft-versus-host-disease-free event-free survival in Fanconi anaemia patients undergoing matched related- and unrelated-donor bone marrow transplantation using alemtuzumab-Flu-Cy: the UK experience.
Bernard F; Uppungunduri CRS; Meyer S; Cummins M; Patrick K; James B; Skinner R; Tewari S; Carpenter B; Wynn R; Veys P; Amrolia P;
Br J Haematol; 2021 May; 193(4):804-813. PubMed ID: 33855694
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of mismatched and unrelated donor hematopoietic stem cell transplantation in Fanconi anemia conditioned with chemotherapy only.
Chao MM; Kuehl JS; Strauss G; Hanenberg H; Schindler D; Neitzel H; Niemeyer C; Baumann I; von Bernuth H; Rascon J; Nagy M; Zimmermann M; Kratz CP; Ebell W
Ann Hematol; 2015 Aug; 94(8):1311-8. PubMed ID: 25862235
[TBL] [Abstract][Full Text] [Related]
12. Haematopoietic cell transplantation in patients with Fanconi anaemia using alternate donors: results of a total body irradiation dose escalation trial.
MacMillan ML; Auerbach AD; Davies SM; Defor TE; Gillio A; Giller R; Harris R; Cairo M; Dusenbery K; Hirsch B; Ramsay NK; Weisdorf DJ; Wagner JE
Br J Haematol; 2000 Apr; 109(1):121-9. PubMed ID: 10848791
[TBL] [Abstract][Full Text] [Related]
13. Successful engraftment without radiation after fludarabine-based regimen in Fanconi anemia patients undergoing genotypically identical donor hematopoietic cell transplantation.
Tan PL; Wagner JE; Auerbach AD; Defor TE; Slungaard A; Macmillan ML
Pediatr Blood Cancer; 2006 May; 46(5):630-6. PubMed ID: 16078221
[TBL] [Abstract][Full Text] [Related]
14. Fludarabine-based reduced intensity conditioning for stem cell transplantation of Fanconi anemia patients from fully matched related and unrelated donors.
Bitan M; Or R; Shapira MY; Aker M; Resnick IB; Ackerstein A; Samuel S; Elad S; Slavin S
Biol Blood Marrow Transplant; 2006 Jul; 12(7):712-8. PubMed ID: 16785060
[TBL] [Abstract][Full Text] [Related]
15. Hematopoietic stem cell transplantation for Diamond Blackfan anemia: a report from the Diamond Blackfan Anemia Registry.
Vlachos A; Federman N; Reyes-Haley C; Abramson J; Lipton JM
Bone Marrow Transplant; 2001 Feb; 27(4):381-6. PubMed ID: 11313667
[TBL] [Abstract][Full Text] [Related]
16. Stem cell transplantation for patients with Fanconi anemia with low-dose cyclophosphamide and antithymocyte globulins without the use of radiation therapy.
Ayas M; Al-Jefri A; Al-Mahr M; Rifai S; Al-Seraihi A; Tbakhi A; Mustafa M; Khairy A; Moussa E; Iqbal A; Shalaby L; El-Solh H
Bone Marrow Transplant; 2005 Mar; 35(5):463-6. PubMed ID: 15654354
[TBL] [Abstract][Full Text] [Related]
17. HLA-haploidentical T cell-depleted allogeneic hematopoietic stem cell transplantation in children with Fanconi anemia.
Zecca M; Strocchio L; Pagliara D; Comoli P; Bertaina A; Giorgiani G; Perotti C; Corbella F; Brescia L; Locatelli F
Biol Blood Marrow Transplant; 2014 Apr; 20(4):571-6. PubMed ID: 24462983
[TBL] [Abstract][Full Text] [Related]
18. Comparison of outcomes after two standards-of-care reduced-intensity conditioning regimens and two different graft sources for allogeneic stem cell transplantation in adults with hematologic diseases: a single-center analysis.
Le Bourgeois A; Mohr C; Guillaume T; Delaunay J; Malard F; Loirat M; Peterlin P; Blin N; Dubruille V; Mahe B; Gastinne T; Le Gouill S; Moreau P; Mohty M; Planche L; Lode L; Bene MC; Chevallier P
Biol Blood Marrow Transplant; 2013 Jun; 19(6):934-9. PubMed ID: 23523970
[TBL] [Abstract][Full Text] [Related]
19. Stem cell transplantation for the treatment of Fanconi anaemia using a fludarabine-based cytoreductive regimen and T-cell-depleted related HLA-mismatched peripheral blood stem cell grafts.
Boulad F; Gillio A; Small TN; George D; Prasad V; Torok-Castanza J; Regan AD; Collins N; Auerbach AD; Kernan NA; O'Reilly RJ
Br J Haematol; 2000 Dec; 111(4):1153-7. PubMed ID: 11167755
[TBL] [Abstract][Full Text] [Related]
20. Results of Allogenic Hematopoietic Stem Cell Transplantation in Fanconi Anemia Caused by Bone Marrow Failure: Single-Regimen, Single-Center Experience of 14 Years.
Tuysuz G; Guler E; Ozel D; Kupesiz A
Biol Blood Marrow Transplant; 2019 Oct; 25(10):2017-2023. PubMed ID: 31199982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
